WK93533 - New Practice for Intralaboratory Blind Quality Control Programs Specific to Seized-Drugs Analysis

Work Item

ASTM WK93533

New Practice for Intralaboratory Blind Quality Control Programs Specific to Seized-Drugs Analysis

1. Scope

This document covers minimum requirements to develop and implement an intralaboratory blind quality control (BQC) program for seized drugs; designed to provide continual assessment of the performance of forensic laboratories conducting the analysis and identification of seized drugs through the use of blind quality control samples.

Keywords

blind quality control; quality assurance; seized-drug analysis; intralaboratory comparison

Rationale

There are no minimum requirements for implementation of seized drug blind quality control programs. The standard will be used to assist forensic laboratories with setting up blind quality control programs.

Details

Developed by Subcommittee: E30.14

Committee: E30

Staff Manager: Kevin Shanahan

Work Item Status

Date Initiated: 01-21-2025

Technical Contact: Agnes Winokur

Item: 003

Ballot: E30.01 (25-01)

Status: In Balloting

New Practice for Intralaboratory Blind Quality Control Programs Specific to Seized-Drugs Analysis

1. Scope

Keywords

Rationale

Details

Work Item Status

Related

New Practice for Intralaboratory Blind Quality Control Programs Specific to Seized-Drugs Analysis

1. Scope

Keywords

Rationale

Details

Work Item Status

Related